• Slider Image
  • Slider Image
  • Slider Image

In the Press

July 10, 2018

Free panel to explore living with inherited cancer risk

According to UC San Diego researchers, curcumin binds to the DYRK2 at the atomic level, and this previously unreported biochemical interaction of curcuminnyone who has cancer in their family tree can benefit from a free expert panel discussion on July 17, featuring Dr. Lisa Madlensky, UC San Diego Moores Cancer Center genetics program director.

July 9, 2018

Crystal Structure Reveals How Curcumin Impairs Cancer

According to UC San Diego researchers, curcumin binds to the DYRK2 at the atomic level, and this previously unreported biochemical interaction of curcumin leads to inhibition of DYRK2 that impairs cell proliferation and reduces cancer burden.

July 6, 2018

Why Vitamin D May Reduce Risk for Breast Cancer

In a new study, researchers get down to the molecular level to determine why vitamin D appears to decrease a woman’s chance of developing breast cancer.

June 28, 2018

CAR-T Immunotherapies May Have a New Player

Study with senior author Dan Kaufman, MD, PhD finds that natural killer cells engineered with chimeric antigen receptors are equally effective and bring different advantages with less toxicity.

June 27, 2018

SDSU Alum Tammy Blackburn Reaches Milestone in Cancer Battle

Blackburn had her family, friends and treatment team gather for the celebration at UC San Diego's Moores Cancer Center, marking the end of her eight months of treatment for stage 2 ductal carcinoma breast cancer.

June 25, 2018

Clinical trial inclusion, specialist collaboration can improve cancer outcomes for those with HIV

Dr. Erin Reid comments on AIDS- versus non-AIDS-defining cancer incidence and aging.

June 24, 2018

SBP and UCSD Researchers Awarded 2018 Padres Pedal The Cause Grants

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce that it has been awarded four Padres Pedal the Cause (PPTC) collaborative grants with UC San Diego Moores Cancer Center.

June 14, 2018

Healthcast: Pregnant with cancer

Dr. Parag Sanghvi and colleagues came up with a plan that let a pregnant cancer patient tonsil cancer keep her baby.

June 8, 2018

Chemo bath: Wiping out cancer where recurrence used to be a probability

Dr. Andy Lowy says that HIPEC is increasing cure rates of several cancer of abdominal organs, and has been successful for patients with cancers of the appendix, colon, ovaries, stomach and mesothelioma.

June 5, 2018

Building the Alpha Stem Cell CLinic Network

Dr. Catriona Jamieson and Mary Donohoe describe in detail how the resulting network of Alpha Stem Cell Clinics has significantly advanced the idea of stem cells and regenerative medicine from much-touted promise to practice.

June 3, 2018

Healthy Living: New study shows most women with early breast cancer don’t need chemo

A major new study shows many breast cancer patients in the early stages of the disease can safely skip chemotherapy, with input from Dr. Richard Schwab.

June 3, 2018

A Love of Science Leads to an Esteemed Career in Cancer Research for Razelle Kurzrock, MD

The ASCO Post Narratives Special Issues features a spotlight on Dr. Razelle Kurzrock.

May 31, 2018

Stem cell banking an unclear path for regenerative medicine: 4 notes

Dr. Dan Kaufman gave his input on stem cell banking research.

May 30, 2018

Frontline Cancer: Are you in for All of Us Research Program?

Cancer scientists and doctors have been pushing and practicing personalized medicine for several years, the idea behind the All of Us Research Program, and nowhere more so than at Moores Cancer Center at UC San Diego Health, says MCC Director Dr. Scott Lippman.

May 24, 2018

Frontline Ibrutinib Plus Obinutuzumab Improves PFS in Phase III CLL Trial

Dr. Michael Choi commented on the initial Icll-07 Filo study data in an Insights segment on OncLive.

May 17, 2018

New Blood Test Rapidly Detects Signs of Pancreatic Cancer

A new diagnostic test developed by researchers at UC San Diego shows promise for detecting pancreatic disease earlier.

May 10, 2018

We Need You: Join All of Us to Advance Precision Medicine

UC San Diego Health researchers call for volunteers to participate in landmark precision medicine research effort, including Dr. Razelle Kurzrock.

May 7, 2018

Non-Aspirin NSAIDs Offer No Survival Advantage in Metastatic RCC

This is the first such study in this group,with findings running counter to prior research in other cancers, with senior author of the study Dr. Rana McKay.

April 25, 2018

Breathe easier with lung cancer screenings

UC San Diego Health established a new lung cancer screening program to help current and former smokers determine their risk for lung cancer. The program is led by Dr. Mark Onaitis.

April 20, 2018

Keytruda Performs Well in Latest Lung Cancer Clinical Trials

The immunotherapy drug has been successful in treating other cancers and the latest trials provide hope for people battling lung cancer. The piece features Dr. Sandip Patel.

April 12, 2018

What You Need to Know About Head and Neck Cancer

Cancer.Net has a new blog about Head and Neck Cancer written by Dr. Kathryn Gold.

April 9, 2018

Cutting-edge cancer drug hobbled by diagnostic test confusion

Physicians struggle to identify which patients are likely to respond to a recently approved therapy, with input from Dr. Razelle Kurzrock.

April 5, 2018

Bryce Olson Wants To Raise Awareness About Precision Medicine. His Rallying Cry: 'Sequence Me'

Bryce Olson's story and collaboration with UC San Diego Moores Cancer Center is told in Forbes, featuring his collaboration team that includes Ida Deichaite, PhD, Director of Industry Relations, Pablo Tamayo, PhD, and Christina Jamieson, PhD.

» More Press

2019 Symposium

The 15th Moores Cancer Center Industry/Academia "Next Generation Precision Oncology" Symposium will be held on Thursday, February 21, 2019.

Confirmed Speakers:

Keynote Speaker

Susan Band Horwitz, PhD

Distinguished Professor, Department of Molecular Pharmacology
Rose C. Falkenstein Chair in Cancer Research
Einstein College of Medicine

Keynote Speaker

Gordon Mills, MD, PhD

Director, Precision Oncology, Knight Cancer Institute
Director, SMMART Trials, Knight Cancer Institute
Wayne and Julie Drinkward Endowed Chair, Precision Oncology, Knight Cancer Institute
Professor, Cell, Developmental and Cancer Biology
OHSU Knight Cancer Institute

Catriona Jamieson, MD, PhD
Deputy Director, UC San Diego Moores Cancer Center
Professor of Medicine and Chief, Division of Regenerative Medicine
Koman Family Presidential Endowed Chair in Cancer Research

Mike Pellini
Chairman of the Board, Foundation Medicine

Michael White, PhD
VP, Tumor Cell Biology, Chief Scientific Officer, Pfizer

2018 Symposium Featured Talks

The 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 22, 2018. See the Agenda here.

Keynote Presentation: Duane Roth Award Lecture
Engineering T-Cells: The Sky is the Limit

Carl June, MD
University of Pennsylvania School of Medicine

Keynote Presentation:
A New Model for Translational Research in the Nonprofit Sector

Peter Schultz, PhD
California Institute for Biomedical Research

Welcome Remarks

Ida Deichaite, PhD, Symposium Organizer, UC San Diego Moores Cancer Center
Pradeep Khosla, PhD, Chancellor, UC San Diego

Welcome Remarks

Thomas Kipps, MD, PhD
Symposium Chair, UC San Diego Moores Cancer Center

In silico drug discovery of dual inhibitors of combinatorial synthetic lethality inhibitors in the era of prevision medical oncology; proof of concept

Donald Durden, MD, PhD
UC San Diego Moores Cancer Center

Visit our Symposium page for more Symposium Featured Talks.

2015 Symposium Slideshow

Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!

2014 Translational Oncology Symposium

A decade of fostering collaborations, fueling innovation & saving lives

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.

The article is available here.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here

Our Symposium Page

9th Symposium Featured on San Diego ABC 10 News

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press